Resultados de la búsqueda 21 – 40 de 147
Clinical and Laboratory Monitoring of Pediatric HIV Infection
Initiation of Antiretroviral Therapy
When to Initiate Antiretroviral Treatment in Children with HIV Infection
Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)
What to Start
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children with HIV
What to Start: Initial Combination Antiretroviral Regimens
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
What Not to Start: Regimens Not Recommended for Initial Antiretroviral Therapy in Infants and Children
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
What to Start: Integrase Strand Transfer Inhibitor Regimens
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
What to Start: Protease Inhibitor–Based Regimens
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy
Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV
Management of People With HIV and Antiretroviral Therapy Experience
Special Considerations for Antiretroviral Therapy Use in Adolescents With HIV
Virologic Failure